John Harrold is a highly experienced professional in the field of pharmacometrics, currently serving as Senior Director of Pharmacometrics at Pfizer since January 2024, following a tenure as Director of Pharmacometrics at Seattle Genetics from April 2020 to December 2023. Prior experience includes roles at Amgen, where John held positions from Preclinical Director to Senior Scientist, focusing on pharmacokinetics and pharmacodynamics. Earlier in John’s career, experience as a Systems Pharmacologist at Pfizer Pharmaceuticals and as a Post Doctoral Fellow at SUNY at Buffalo involved significant contributions to modeling signal transduction and PKPD in cancer therapies. John also served as a Peace Corps Volunteer and Visiting Lecturer, contributing to curriculum development in biology and physics while earning an MS and PhD in Chemical Engineering from the University of Arkansas and the University of Pittsburgh, respectively.
This person is not in any teams
This person is not in any offices